Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1141 of 5804
-
New iron supplement could help celiac kids recover faster
Disease control Recruiting nowCeliac disease in children is frequently associated with iron deficiency and/or iron deficiency anemia due to intestinal malabsorption and chronic inflammation. Although a gluten-free diet is the standard treatment and can restore iron balance over time, there is currently no cle…
Phase: NA • Sponsor: Istituto Giannina Gaslini • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New antibody cocktail takes on tough lupus kidney disease
Disease control Recruiting nowThis study is researching a particular group of experimental drugs administered for a short period in the treatment of participants with Lupus Nephritis (LN). The main aim of the current study is to see how safe and tolerable the study drugs are in a long-term follow-up. This i…
Phase: PHASE1 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Magic mushroom compound probed as brain tool against opioid addiction
Knowledge-focused Recruiting nowThe goal of this study is to test addiction-related brain circuitry (motivation/reward and inhibition) as well as neurocognitive circuitry prior to and following low or high dose psilocybin (PEX010 from Filament). Using fMRI, brain circuits will be examined that are relevant to d…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New hope for stubborn gout: experimental drug PRX-115 enters phase 2 trial
Disease control Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled phase II study assessing the efficacy, safety, and dosing regimen selection of multiple IV infusions of PRX-115 over 24 weeks, with or without MTX, versus the respective placebos in adult patients with gout.
Phase: PHASE2 • Sponsor: Protalix • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can talk therapy tame PTSD behind bars?
Symptom relief Recruiting nowThis research will help identify if a PTSD treatment group, called Cognitive Processing Therapy (CPT), that is used in community settings is helpful in reducing PTSD symptoms among people who are incarcerated. The goal of CPT is to create a space for people to modify unhelpful be…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
CT scans could make heart stent surgery safer and faster
Disease control Recruiting nowThe OPTIMAL randomized clinical trial has been designed to compare two imaging strategies and to test the hypothesis that a calcium modification strategy informed by coronary CT angiography (CCTA) will improve procedural efficiency and effectiveness compared with the current stan…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a single, smarter surgery spare bladder cancer patients a second operation?
Disease control Recruiting nowBackground: In European Association of Urology (EAU) Guidelines, the vast majority of non-muscle-invasive bladder cancers (NMIBCs) undergo a primary transurethral resection of the bladder tumor (TURBT) followed by a repeat TURBT (Re-TURBT). The Re-TURBT is recommended due to the …
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Gene therapy injection aims to restore pigment in Children's eyes
Disease control Recruiting nowOculocutaneous albinism (OCA) is the most common type of albinism. People with OCA have little or no pigment (melanin) in their eyes, skin, and hair. This often leads to symptoms such as sensitivity to light, crossed or misaligned eyes, reduced vision, and involuntary eye movemen…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New catheter aims to tame stubborn AFib
Disease control Not yet recruitingThis clinical trial aims to evaluate the safety and efficacy of pulmonary vein isolation (PVI), focal, and linear ablation in patients with persistent atrial fibrillation (PersAF) using a novel shape-adaptive pulsed field ablation (PFA) catheter (PFLotus, EnChannel Medical) integ…
Phase: NA • Sponsor: The Third People's Hospital of Chengdu • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New CAR-T therapy aims to fight hard-to-treat blood cancers
Disease control Not yet recruitingThis single-arm, open-label pilot study will assess the safety and efficacy of RN1701, a bispecific CD19/CD20-targeted allogeneic CAR-T-cell product, in patients with relapsed or refractory B-cell lymphoma. Up to 19 participants will be enrolled in a conventional 3 + 3 dose-escal…
Phase: PHASE1 • Sponsor: YANRU WANG • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New study aims to end asthma vs. COPD confusion with High-Tech imaging
Diagnosis Recruiting nowThis study aims to improve the diagnosis and treatment prediction of asthma and chronic obstructive pulmonary disease (COPD) by combining quantitative chest computed tomography (CT) imaging with multi-omics data. Adults with asthma or COPD will be enrolled and undergo routine cl…
Sponsor: Korea University Guro Hospital • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New combo aims to fix Chemo's lingering side effect in cancer survivors
Disease control Recruiting nowThis is a prospective, randomized, open-label, active-controlled study to evaluate the efficacy and safety of Romiplostim N01 plus all-trans retinoic acid (ATRA) compared with Romiplostim N01 alone in adults with persistent isolated chemotherapy-induced thrombocytopenia (PICIT) a…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Gene-Silencing shot aims to quiet hepatitis b for good
Disease control Recruiting nowThis is an open-label study with single- and multiple-ascending dose arms followed by a dose expansion arm. The primary objective of the study is to determine the safety and tolerability of CRMA-1001 in adult participants with Chronic Hepatitis B. In addition, the pharmacokinetic…
Phase: PHASE1, PHASE2 • Sponsor: nChroma Bio • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eczema pill shows promise in early trial
Symptom relief Recruiting nowThe goal of this clinical trial is to learn about the safety and effectiveness of ENV-294 in adults with moderate to severe atopic dermatitis. The main questions it will answer are: * Is there an impact on the severity and area of atopic dermatitis when participants take ENV-29…
Phase: PHASE2 • Sponsor: Enveda Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Could a daily pill boost independence in down syndrome?
Symptom relief Recruiting nowThe goal of this clinical trial is to identify if AEF0217 show an improvement in adaptive behaviors (daily life activities) in adults and older adolescents with Down Syndrome. It will also learn about the safety of AEF0217. The main questions it aims to answer are: * Does AEF02…
Phase: PHASE2 • Sponsor: Aelis Farma • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
New hope for rare thymic cancer: targeted drug trial launches
Disease control Not yet recruitingThis is a single-arm, phase II study to evaluate the efficacy and safety of Sacituzumab Tirumotecan, a TROP2-directed antibody-drug conjugate, in patients with advanced thymic epithelial tumors who have received second-line or later therapy.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New device hopes to restore arm function after stroke
Disease control Recruiting nowThis is a multicenter, randomized, controlled clinical study evaluating the safety and effectiveness of the Spatial StimelMD (SSMD) device for upper-limb neuromotor rehabilitation in adults with impairment following stroke or traumatic brain injury (TBI). Participants will be ra…
Phase: NA • Sponsor: Motion Informatics LTD • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can tailored magnetic pulses ease Parkinson's symptoms?
Symptom relief Recruiting nowThis clinical trial aims to evaluate whether individualized targeted repetitive transcranial magnetic stimulation (rTMS) can improve motor and non-motor symptoms in patients with parkinsonian disorders. The main question it aims to answer is: * Does individualized targeted rTMS …
Phase: NA • Sponsor: Peking University First Hospital • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Nipple fluid DNA test could spare thousands from unnecessary breast surgery
Diagnosis Recruiting nowThis is a prospective, single-center diagnostic study testing whether a new, minimally invasive analysis of nipple fluid can distinguish benign from malignant causes of pathologic nipple discharge. Many patients with bloody or blood-tinged nipple discharge undergo surgery to make…
Sponsor: Hubei Cancer Hospital • Aim: Diagnosis
Last updated Jul 19, 2026 00:00 UTC
-
Could mixing HPV vaccines offer better protection?
Prevention OngoingThis study aims to assess the immunogenicity and safety of a sequential 2vhpv to 9vhpv immunization schedule in girls aged 9-14 years
Phase: PHASE4 • Sponsor: Zhejiang Provincial Center for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 13:08 UTC